C. Zielinski
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Genetics top 5%
- Dermatology top 2%
- Molecular Biology
- Co-authors
- David CameronDamien C. WeberGary H. LymanNora KearneyMatti AaproJulia BohliusRuth PettengellJan Walewski
- Topics
- Cancer Treatment and Pharmacology (20 papers)HER2/EGFR in Cancer Research (10 papers)Advanced Breast Cancer Therapies (7 papers)
- Partner nations
- AustriaSwitzerlandUnited States
In The Last Decade
C. Zielinski
48 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 93
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 603
- Genetics 457
- Dermatology 270
- Molecular Biology 221
Countries citing papers authored by C. Zielinski
This map shows the geographic impact of C. Zielinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Zielinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Zielinski more than expected).
Fields of papers citing papers by C. Zielinski
This network shows the impact of papers produced by C. Zielinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Zielinski. The network helps show where C. Zielinski may publish in the future.
Co-authorship network of co-authors of C. Zielinski
This figure shows the co-authorship network connecting the top 25 collaborators of C. Zielinski. A scholar is included among the top collaborators of C. Zielinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Zielinski. C. Zielinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 65 | |
| 3 | 16 | |
| 4 | 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursbreakdown → | 777 |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 52 | |
| 8 | Jun and Fos family protein expression in human breast cancer: correlation of protein expression and clinicopathological parameters. | 50 |
| 9 | 85 | |
| 10 | 368 | |
| 11 | 7 | |
| 12 | 18 | |
| 13 | 32 | |
| 14 | 2 | |
| 15 | 19 | |
| 16 | 266 | |
| 17 | 29 | |
| 18 | 12 | |
| 19 | 64 | |
| 20 | 1 |
About C. Zielinski
C. Zielinski is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 51 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (20 papers), HER2/EGFR in Cancer Research (10 papers) and Advanced Breast Cancer Therapies (7 papers). The work is most often cited by research in Oncology (1.5k citations), Otorhinolaryngology (160 citations) and Dermatology (270 citations). C. Zielinski has collaborated with scholars based in Austria, Switzerland and United States. Frequent co-authors include David Cameron, Damien C. Weber, Gary H. Lyman, Nora Kearney, Matti Aapro, Julia Bohlius, Ruth Pettengell, Jan Walewski, Vivianne C. G. Tjan‐Heijnen and Michael Hejna. Their work appears in journals such as Journal of Clinical Oncology, European Heart Journal and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.